{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:46:26Z","timestamp":1787064386814,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejim.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T16:47:01Z","timestamp":1663433221000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["COVID vaccine-induced immune thrombotic thrombocytopenia: Rare but relevant"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-7336","authenticated-orcid":false,"given":"Andreas","family":"Greinacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.09.012_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.08.002","article-title":"Potential mechanisms of vaccine-induced thrombosis","volume":"105","author":"Marietta","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0002","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jth.15572","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): update on diagnosis and management considering different resources","volume":"20","author":"Greinacher","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2022.09.012_bib0004","unstructured":"World Health Organization. Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) folloWing vaccination to prevent coronavirus disease (COVID-19). 2021. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/342999\/WHO-2019-nCoV-TTS-2021.1-eng.pdf."},{"key":"10.1016\/j.ejim.2022.09.012_bib0005","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0006","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0007","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0008","unstructured":"Australian Government, Department of health and aged care, therapeutic goods administration. COVID-19 vaccine weekly safety report - 23-09-2021. 2021. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-weekly-safety-reports\/covid-19-vaccine-weekly-safety-report-23-09-2021."},{"key":"10.1016\/j.ejim.2022.09.012_bib0009","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","volume":"385","author":"Salih","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.09.012_bib0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2021014240","article-title":"ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia","volume":"140","author":"Karnes","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2022.09.012_bib0011","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1182\/bloodadvances.2022007673","article-title":"Genome-wide association study of platelet factor 4\/heparin antibodies in heparin-induced thrombocytopenia","volume":"6","author":"Giles","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.ejim.2022.09.012_bib0012","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3324\/haematol.2021.280154","article-title":"Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines","volume":"107","author":"Michalik","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2022.09.012_bib0013","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2022.09.012_bib0014","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2022.09.012_bib0015","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1016\/S2542-5196(22)00097-3","article-title":"Vulnerability and one health assessment approaches for infectious threats from a social science perspective: a systematic scoping review","volume":"6","author":"Jeleff","year":"2022","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.ejim.2022.09.012_bib0016","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"Nicolai","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2022.09.012_bib0017","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:36:42Z","timestamp":1760607402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":17,"alternative-id":["S0953620522003326"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.09.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID vaccine-induced immune thrombotic thrombocytopenia: Rare but relevant","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}